Abstract 924: The androgen receptor antagonist darolutamide shows strong antitumor efficacy in patient- and cell line-derived xenograft prostate cancer models

2019 ◽  
Author(s):  
Pascale Lejeune ◽  
Antje Wengner ◽  
Simon J. Baumgart ◽  
Ekaterina Nevedomskaya ◽  
Eva Corey ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Receptor Antagonist ◽  
Cell Line ◽  
Antitumor Efficacy ◽  
Androgen Receptor Antagonist ◽  
Cancer Models

scholarly journals Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models

2019 ◽  
Vol 145 (5) ◽  
pp. 1382-1394 ◽  
Author(s):  
Tatsuo Sugawara ◽  
Simon J. Baumgart ◽  
Ekaterina Nevedomskaya ◽  
Kristin Reichert ◽  
Holger Steuber ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Receptor Antagonist ◽  
Androgen Receptor Antagonist ◽  
Cancer Models

scholarly journals Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer

2015 ◽  
Vol 6 (8) ◽  
pp. 908-912 ◽  
Author(s):  
Aaron Balog ◽  
Richard Rampulla ◽  
Gregory S. Martin ◽  
Stanley R. Krystek ◽  
Ricardo Attar ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Receptor Antagonist ◽  
Androgen Receptor Antagonist
Sign in / Sign up

Export Citation Format

Share Document